Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Blood|August 22, 2018
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profilesJohannes C Hellmuth, Abner Louissaint, Monika Szczepanowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2019
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer CellsJustin Cidado, Scott Boiko, Theresa Proia, et al.
Blood|December 14, 2017
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphomaSteven M Horwitz, Raphael Koch, Pierluigi Porcu, et al.
British Journal of Haematology|September 27, 2014
Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemiaMarc R Mansour, Casie Reed, Amy R Eisenberg, et al.
American Journal of Clinical Pathology|August 15, 2025
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implicationsAli AlJabban, Roberta S Azevedo, Katherine Antel, et al.
Stem Cells (Dayton, Ohio)|May 7, 2009
Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation WorkshopTheodor M Fliedner, Nelson J Chao, Judith L Bader, et al.
Blood Advances|January 4, 2018
Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in miceTomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2018
Parp3 promotes long-range end joining in murine cellsJacob V Layer, J Patrick Cleary, Alexander J Brown, et al.
Blood|July 16, 2016
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapyVindi Jurinovic, Robert Kridel, Annette M Staiger, et al.
Pageof 17